 |
|
|
| |
Oral Once-Daily 300 mg ALG-000184, a Novel Capsid Assembly Modulator, Demonstrated Profound and Sustained Suppression of HBV DNA to < 10 IU/mL in All Treatment-Naïve (TN) or Currently-Not-Treated (CNT) Subjects with Chronic HBV Infection
|
| |
| |
AASLD 2025 Nov 7-11 Wash DC
Man-Fung Yuen1, Kosh Agarwal2, Alina Jucov3, Alexei Haceatrean3, Min Wu4, Kha Le4, Jen Rito4, Lawrence M. Blatt4, Sushmita Chanda4, Tse-I Lin4, Hardean E. Achneck4, Edward Gane5
|
| |
|
|
|
|
|
